The Inner Circle acknowledges, Joe Zepeda as an Inner Circle Lifetime member
JOLIET, Ill., May 30, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Joe Zepeda is acknowledged as an Inner Circle Lifetime for his contributions as a Veteran Waste Management Leader Driving Operational Excellence Across 14 States.
Joe Zepeda brings over three decades of hands-on experience to his role as a senior operations leader in the national waste management industry. Currently overseeing contract management and operations across 14 states with a fleet of 300 trucks, Joe plays a pivotal role in the success of his organization, reporting directly to the CEO and managing three direct reports.
Joe's career began in entry-level roles—working as a laborer, truck driver, dispatcher, and salesman—before advancing into leadership. His deep understanding of the business, combined with a strong work ethic, has earned him several growth awards and operational achievements. Today, he is recognized for his strategic approach to contract bidding, operational execution, and team mentorship.
He earned a bachelor's degree in business administration from Lewis University in 2023 and remains actively engaged in industry organizations such as the Solid Waste Association of North America, Hispanic Pro, and the Illinois Landscaping Association. He has also contributed educational content focused on workforce development for Latino employees in the landscaping and waste sectors.
Joe takes the most pride in being a father to his three children—Jose, Joanna, and Jay—whom he credits as his greatest inspiration. He enjoys golfing, traveling, dining out with his partner Christina, and coaching youth baseball in his community.
Looking ahead, Joe plans to pursue executive-level certifications and aspires to become Chief Operating Officer, continuing to lead by example and champion operational innovation in the waste management sector. His philosophy centers on mentorship, continuous growth, and the importance of investing in people to build lasting success.
Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com
View original content:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-joe-zepeda-as-an-inner-circle-lifetime-member-302469682.html
SOURCE The Inner Circle
Se produjo un error al recuperar la información
Inicia sesión para acceder a tu portafolio
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
First-of-Its-Kind Platts Milling Wheat Marker Released by S&P Global Commodity Insights
The Marker provides a comprehensive price assessment that includes wheat from all the key Black Sea ports and reflects typical buying practice in the most important export region. LONDON, June 2, 2025 /PRNewswire/ -- Platts, part of S&P Global Commodity Insights, the leading independent provider of information, data, analysis, benchmark prices and workflow solutions for the commodities and energy markets, today launched the Platts Milling Wheat Marker, the first daily spot market price assessment of its kind designed to deliver a transparent and robust benchmark for milling wheat trade in the Black Sea region. The aim of the price assessment is to address the market's need for a key reference point for assessing and planning purchases based on the diversity of available supply routes. "Through the Milling Wheat Marker, we are providing a common reference point to reflect the price of wheat available from the world's most important export region," said Piero Carello, Head of Agriculture and Food Pricing at S&P Global Commodity Insights. "This market-first assessment enhances transparency and better facilitates decision making, especially in market environments where buyers may need to pivot to alternative supply sources in response to disruptions on specific routes." The Platts Milling Wheat Marker is underpinned by the Platts Market-on-Close price assessment methodology and reflects the end-of-day value, as determined by buyers and sellers in the open markets, for 12.5% protein milling wheat shipped on handysize vessels. The Black Sea region plays a crucial role in the global wheat market, accounting for 38% of global wheat exports during the marketing year 2023-2024 (July-June), according to S&P Global Commodity Insights data. The region's four largest exporters shipped a total of 83.8 million metric tons of wheat, with Russia contributing 54.7 million metric tons, Ukraine 18.6 million metric tons, and Romania and Bulgaria 10.5 million metric tons. This area is a key supplier to major global wheat buyers, particularly in the Middle East and Africa, where domestic supply falls short of demand. The Platts Milling Wheat Marker is determined using the most competitive values from Platts' three relevant wheat assessments: Free on Board (FOB) Russia for 12.5% protein wheat, FOB Ukraine for 11.5% protein wheat, and FOB Constanta-Varna-Burgas for 12.5% protein wheat. The Constanta-Varna-Burgas assessment includes the shipping ports of Constanta in Romania and Varna and Burgas in Bulgaria, crucial for the EU's agricultural exports from the Black Sea. A quality normalization is applied to the Ukraine 11.5% assessment to account for its lower protein content, ensuring that the marker reflects like-for-like market dynamics. As a leading price reporting agency, Platts serves as a key source of benchmark price assessments in the physical commodity markets. Since 2014, Platts has been evaluating Black Sea grains, and these price assessments are frequently recognized in the market as an important reference. The Platts Milling Wheat Marker daily assessments and monthly averages will be published on Europe Grain Assessments (PAA1440) and Europe Grain Monthly Averages (PAA1612), available in Platts Daily Grains and on Platts Connect. Additional calculations, including Ukraine's monthly average difference and daily normalization assessments, can also be accessed on Platts Connect. The subscriber note can be accessed here. For more information, access the Platts Global Grains and Oilseeds Specifications Guide. Media Contacts Global/EMEA: Paul Sandell, + 44 (0)7816 180039, Kathleen Tanzy, +1 917-331-4607, Melissa Tan, +65-6597-6241, About S&P Global Commodity InsightsAt S&P Global Commodity Insights, our complete view of global energy and commodities markets enables our customers to make decisions with conviction and create long-term, sustainable a trusted connector that brings together thought leaders, market participants, governments, and regulators and we create solutions that lead to progress. Vital to navigating commodity markets, our coverage includes oil and gas, power, chemicals, metals, agriculture, shipping and energy transition. Platts® products and services, including the most significant benchmark price assessments in the physical commodity markets, are offered through S&P Global Commodity Insights.S&P Global Commodity Insights is a division of S&P Global (NYSE: SPGI). S&P Global is the world's foremost provider of credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help many of the world's leading organizations navigate the economic landscape so they can plan for tomorrow, today. For more information visit View original content to download multimedia: SOURCE S&P Global Commodity Insights
Yahoo
16 minutes ago
- Yahoo
BioArctic's Capital Markets Day 2025 - entering a new era of growth
STOCKHOLM, June 2, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day. The event, which starts at 10:30 CET, will be broadcast live online. Over the past 20 years, BioArctic has built a thriving company based on a foundation of solid science and innovation, strong finances and an organization with well-educated staff and a value-driven corporate culture. At the Capital Markets Day, management will outline BioArctic's ambitions for 2030 which focuses on building Sweden's next major pharmaceutical company. This will be achieved by: building a balanced and broad pipeline with projects in all stages of development, adding additional successful global partnerships, and establishing Leqembi® as a treatment for Alzheimer's disease in the Nordics ensuring finances that allow for both investing in growth while giving recurring dividends to shareholders. To achieve this, the company will accelerate innovation into a broader area of severe brain diseases, proactively work with business development to maximize the value of each project, and work to ensure a successful launch of Leqembi in the Nordic region. The presentation for the Capital Markets Day can be found on A recording of the Capital Markets Day will be available later today on BioArctic's website. AGENDA 10:30 BioArctic today and tomorrow Precision neurology and severe brain disease experiencing unprecedented opportunities for innovation. Chief Executive Officer Gunilla Osswald will discuss how BioArctic is positioning itself to capture these global possibilities and outline the company's ambitions toward 2030. 11:00 FinancialsFollowing the recent license agreement with Bristol Myers Squibb and with continuous royalties from Leqembi sales, BioArctic expects to achieve profitability from this year onwards. Anders Martin-Löf, Chief Financial Officer, will outline what this strengthened financial position means for shareholders and BioArctic's future opportunities. 11:20 R&D StrategyBased on the same principle as Leqembi, BioArctic has built a project portfolio with selective antibodies targeting aggregated forms of misfolded proteins in the brain. Chief R&D Officer Johanna Fälting will outline the overarching research strategy and explain how BioArctic's integrated antibody and BrainTransporter™ platforms create opportunities across several disease areas. 11:50 Q&A 12:10 Lunch 13:00 LeqembiLeqembi is the first fully approved disease-modifying treatment for early Alzheimer's disease, marking a transformational shift in the treatment landscape. Anna-Kaija Grönblad, Chief Commercial Officer, will discuss this evolving paradigm, provide insights into global and European market developments, and outline BioArctic's preparations for the Nordic launch. 13:20 Key opinion leader: Disease modifying treatment for Alzheimer's disease in clinical useSince the initial approval of Leqembi in the United States in January 2023, clinicians have gained important real-world experience with this groundbreaking therapy for early Alzheimer's disease. Professor Lawrence S. Honig from Columbia University's Department of Neurology will present clinical insights from US practice and discuss the practical challenges and opportunities of implementing this new treatment paradigm. 14:00 Q&A 14:15 BrainTransporter-technologyBiological drugs hold enormous potential for treating brain diseases, but the blood-brain barrier has historically prevented their effective delivery. Chief Scientific Officer Per-Ola Freskgård will present how BioArctic's breakthrough BrainTransporter technology can deliver antibodies with up to 70 times greater brain exposure and superior distribution and discuss the commercial opportunities this proprietary platform creates. 14:55 ExidavnemabBioArctic's antibody exidavnemab targets alpha-synuclein, a key protein involved in multiple neurodegenerative conditions. Gabrielle Åhlberg Hillert, Chief Medical Officer, will provide an update on the Phase 2 program, explain how exidavnemab differentiates from other late-stage antibodies, and discuss how it could address significant unmet medical needs in alpha-synuclein diseases such as Parkinson's disease, Multiple System Atrophy, and Lewy body dementia. 15.15 Q&A 15.30 Concluding remarks Short summary by Gunilla Osswald, Chief Executive Officer The information was released for public disclosure, through the agency of the contact persons below, on June 2, 2025, at 10:30 CET. For further information, please contact: Oskar Bosson, VP Communications and Investor RelationsE-mail: +46 70 410 71 80 Charlotte af Klercker, Senior Director Sustainability and CommunicationsE-mail: Telephone: +46 73 515 09 70 About BioArctic ABBioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company is the originator of Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with Eisai. BioArctic has a broad research portfolio within Alzheimer's disease, Parkinson's disease, ALS and enzyme deficiency diseases. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which improves the transport of drugs into the brain. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For more information, please visit This information was brought to you by Cision The following files are available for download: BioArctic’s Capital Markets Day 2025 â€" entering a new era of growth View original content: SOURCE BioArctic Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Bloomberg Expands HQLA Solution to Middle East as International Banks Increase Presence in Region
The HQLA solution helps monitor bank liquidity requirements under Basel III and now includes local rules for the United Arab Emirates (UAE) and Qatar NEW YORK, June 2, 2025 /PRNewswire/ -- Bloomberg today announced the release of their High-Quality Liquid Assets (HQLA) solution in the Middle East, expanding a Basel III regulatory data solution to the region and equipping financial institutions to monitor liquidity requirements in accordance with the Central Bank of the United Arab Emirates (UAE) Rulebook and the Qatar Central Bank's prudential regulations. One of the key reforms introduced by Basel III, the Liquidity Coverage Ratio (LCR), requires financial institutions to hold an adequate amount of unencumbered High-Quality Liquid Assets (HQLA) that can be converted easily and immediately into cash. The Basel LCR framework has been transcribed into each jurisdiction's national law in different ways, requiring a bespoke and customized solution for each jurisdiction to help banks identify asset classes eligible for inclusion in the HQLA. "As international banks expand into the Middle East, they are looking to Bloomberg as their trusted regulatory data partner to establish strong compliance processes with the local regulatory regime," said Leila Sadiq, Global Head of Enterprise Data Content at Bloomberg. "With this expansion, Bloomberg brings our robust HQLA data set and best in class reference data to Middle East jurisdictions to help all financial institutions including local banks, hedge funds and private banks in addition to international banks meet local liquidity and regulatory requirements." Bloomberg's HQLA solution now covers 12 jurisdictions and offers a set of data points to assist clients in complying with Basel III's LCR requirements and regulatory reporting. This data, which firms can also use for calculating their standardized credit risk capital requirements, consists of 4 main data sets: HQLA Classification - 33 security-level data points including the level of eligibility for different jurisdictions, Organisation for Economic Co-operation and Development (OECD) classifications and standardized risk weight. 30-day Stress Period Price Drop Metrics - Five data points providing the most recent single largest 30 calendar day price drop over relevant stress periods (under two methodologies). Liquid & Readily Marketable - 19 data points to assist clients in determining if fixed income securities are liquid and readily marketable. Central Bank Eligibility - Three data points to assist in determining if a security is accepted as eligible collateral by 14 major global central banks, together with the corresponding haircut values. HQLA is a high quality dataset available to bank treasurers, traders, regulatory reporting managers, risk officers and investment professionals via the Bloomberg Terminal as well as through an enterprise data feed. It was developed with input from regulators and industry experts in order to assure the precision and accuracy of the classifications provided. The HQLA solution is part of Bloomberg's Regulatory and Accounting Product suite, which helps professionals at banks, asset managers, insurers and other financial organizations navigate an increasingly complex regulatory and accounting disclosure environment. About Bloomberg Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit or request a demo. View original content to download multimedia: SOURCE Bloomberg Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
